Ministry of Health: Initial Public Drug System Establishment

Zheng Hong, director of the Department of Drug Policy and Essential Drugs of the Ministry of Health, introduced today that the national basic medicine system has been initially established, the network of rural health service systems has been further strengthened, and the burden on the masses has been reduced.

The Ministry of Health held a regular press conference today to introduce progress in the promotion of the basic drug system and an analysis of medical expenses in public hospitals in Grade 2 and above in the first half of the year.

Zheng Hong introduced that accelerating the advancement of the national essential medicine system is a difficult and important point in the overall medical reform. All localities adhere to the basic direction of ensuring basic, strong grass-roots, and construction mechanisms, to comprehensively cover, standardize procurement, and implement compensation. Five aspects, including the innovation mechanism and the construction of a meshed network, are the starting point for comprehensively advancing the comprehensive reform of the state's basic medicine system and primary health care institutions, achieving significant progress and initial results.

The first is the initial establishment of a national essential medicine system. At present, 31 provinces (autonomous regions, municipalities) and Xinjiang Production and Construction Corps all have implemented basic medicines at all government-run grassroots medical and health institutions, and have implemented zero-salt sales, and the country’s basic medicine system has been initially established.

Second, the comprehensive reform has been steadily progressing and the new mechanism has been fully established. The emphasis placed on comprehensive reforms at the grass-roots level has been markedly improved. Work has continued to increase and work progress has accelerated. This is mainly reflected in the new progress made in the central procurement of essential medicines, the gradual improvement of the compensation mechanism for basic medical and health institutions, and the success in the personnel and distribution system reforms in primary health care institutions.

Third, the network of rural health service systems was further built up. As of the end of September, the basic drug system was fully covered in six provinces in Shanghai and all the village clinics of the Xinjiang Production and Construction Corps, and was implemented in more than 60% of village clinics in seven provinces such as Beijing.

Fourth, the burden of medication for the masses has been reduced. After the implementation of the basic drug system at the grass-roots level, the masses of the people have effectively received benefits, mainly manifested as “a drop of one liter”. "A drop" mainly refers to the "zero margin" sales of basic drugs and the provincial centralized procurement. The sales price of essential drugs at the grass-roots level has declined significantly before the implementation of the system, and the average sales price of essential drugs at the grass-roots level has declined from the average before the implementation of the system. About 25%. "One-liter" mainly means that the proportion of Medicare reimbursement has risen significantly.

The basic drug use and reimbursement policies were gradually put in place, basic drugs were all included in the basic Medicare drug reimbursement list, and the reimbursement rate was significantly higher than non-essential drugs. The proportion of hospitalization expenses reimbursed within the NCMS and urban residents' medical insurance policy has reached more than 60%, and some of the co-ordinated regions have increased to 70%. More than 90% of co-ordinating regions have conducted outpatient consultations.

Fifth, comprehensively monitor and evaluate the basic drug system. In February 2010, government-run grass-roots medical institutions in 30% of the country implemented a national essential medicine system. The Ministry of Health, with the support of funds from international cooperation projects, established a sample of 65 grass-roots monitoring sites in 13 provinces in eastern, central and western China in a timely manner. By September of this year, the monitoring scope has been expanded to 80 monitoring sites in 18 provinces. The monitoring results in 2010 showed that the implementation of the basic drug system has played an active role in effectively reducing drug prices, promoting rational drug use, establishing new mechanisms for grassroots operations, and improving the utilization rate of primary health care services.

According to the requirements of the Ministry of Health, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps Health Department Bureau have fully carried out the 2011 national essential drug system monitoring and evaluation work, which will help to fully grasp the local work dynamics and urge local governments to further promote the country. The basic drug system and comprehensive reforms at the grassroots level are also conducive to summarizing the promotion of local characteristics and providing basis for further improving policies.

In addition, the Ministry of Health has also used central financial support to carry out training for pharmacy personnel in 22 provinces (autonomous regions and municipalities) in the central and western regions and 30,500 township hospitals of the Xinjiang Production and Construction Corps to consolidate the results of implementation of the national essential medicine system and improve rural areas. Health service capacity to promote the rational use of basic medicines in the country. The food and drug regulatory authorities at all levels have effectively improved the quality of essential drugs by implementing new standards for drug quality, carrying out basic drug safety supervision, implementing sampling tests for all varieties of essential drugs, conducting electronic monitoring of all types of essential drugs, and strengthening monitoring of adverse reactions to essential drugs. Regulatory work. (According to the Chinese net text finishing)

HUMID BH

High Flow Nasal Cannula(HFNC) oxygen therapy is a form of non –invasive respiratory support, which comprises an air oxygen blender, an active humidifier, a single heated circuit and a nasal cannula. It delivers adequately heated and humidified medical gas up to 10-60L/min, and is considered to have a number of physiological effects: reduction of anatomical dead space, PEEP effect, constant fraction of inspired oxygen and good humidification.
It is widely used in RICU and ICU.

HUMID BH,Hfnc For Infants,Hfnc Flow Peep,High Flow Oxygen Delivery

Shenyang RMS MEDICAL TECH CO.,LTD , https://www.medicalrms.com